Choice Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

Choice Therapeutics General Information

Description

Manufacturer of pharmaceutical products. The company develops and manufactures medical devices for burns, advanced wound care and surgical site infections. It specializes in TheraBond and TheraBond 3D product lines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 190 Industrial Road
  • Wrentham, MA 02093
  • United States
+1 (774)
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 190 Industrial Road
  • Wrentham, MA 02093
  • United States
+1 (774)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Choice Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Choice Therapeutics‘s full profile, request access.

Request a free trial

Choice Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Choice Therapeutics‘s full profile, request access.

Request a free trial

Choice Therapeutics FAQs

  • When was Choice Therapeutics founded?

    Choice Therapeutics was founded in 2006.

  • Who is the founder of Choice Therapeutics?

    James Hutchens is the founder of Choice Therapeutics.

  • Where is Choice Therapeutics headquartered?

    Choice Therapeutics is headquartered in Wrentham, MA.

  • What industry is Choice Therapeutics in?

    Choice Therapeutics’s primary industry is Medical Supplies.

  • Is Choice Therapeutics a private or public company?

    Choice Therapeutics is a Private company.

  • What is the current valuation of Choice Therapeutics?

    The current valuation of Choice Therapeutics is .

  • What is Choice Therapeutics’s current revenue?

    The current revenue for Choice Therapeutics is .

  • How much funding has Choice Therapeutics raised over time?

    Choice Therapeutics has raised $4.65M.

  • Who are Choice Therapeutics’s investors?

    Alliqua BioMedical has invested in Choice Therapeutics.

  • When was Choice Therapeutics acquired?

    Choice Therapeutics was acquired on 31-Aug-2017.

  • Who acquired Choice Therapeutics?

    Choice Therapeutics was acquired by Argentum Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »